Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Vaccinia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01169584
What this trial is testing

Safety Study of Recombinant Vaccinia Virus to Treat Refractory Solid Tumors in Pediatric Patients

Who this might be right for
NeuroblastomaRhabdomyosarcomaLymphoma+2 more
Jennerex Biotherapeutics 6
Early research (Phase 1)Study completedNCT01418235
What this trial is testing

Safety of and Immune Response to a DNA HIV Vaccine Boosted With a Modified Vaccinia HIV Vaccine and Protein HIV Vaccine in Healthy Adults

Who this might be right for
HIV SeronegativityHIV Preventive Vaccine
HIV Vaccine Trials Network 184
Large-scale testing (Phase 3)Study completedNCT01056770
What this trial is testing

Safety and Efficacy of CJ Smallpox Vaccine in Healthy Volunteers

Who this might be right for
Smallpox
Seoul National University Hospital 88
Post-approval studies (Phase 4)Study completedNCT01827917
What this trial is testing

The Protection Effect of Speeda® Rabies Vaccine for Human Use

Who this might be right for
Rabies Vaccine Allergy
Beijing Center for Disease Control and Prevention 37
Early research (Phase 1)Study completedNCT00427453
What this trial is testing

A Phase I Study of the Safety and Immunogenicity of a Recombinant MVA Vaccine Encoding a Secreted Antigen From M. Tuberculosis, Antigen 85A, Delivered Intradermally by a Needle Injection in Healthy Volunteers Who Have Received BCG Immunisation 1 Month Previously

Who this might be right for
Tuberculosis
University of Oxford 12
Early research (Phase 1)Not Yet RecruitingNCT07170592
What this trial is testing

OTS-412 (Recombinant Oncolytic Vaccinia Virus) in Treatment-refractory Solid Tumor Patients

Who this might be right for
Treatment-Refractory Solid Tumors
Bionoxx Inc. 24
Testing effectiveness (Phase 2)Study completedNCT00112957
What this trial is testing

Vaccine Therapy in Patients With Stage II, III, or IV Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPeritoneal Cavity Cancer
Ludwig Institute for Cancer Research 23
Early research (Phase 1)Study completedNCT01571960
What this trial is testing

Evaluating the Safety and Immune Response of a Prime-Boost HIV Vaccine Regimen in Healthy, HIV-Uninfected, Vaccinia-Naive Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 48
Testing effectiveness (Phase 2)Study completedNCT03294083
What this trial is testing

Recombinant Vaccinia Virus in Combination With Cemiplimab for Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
SillaJen, Inc. 95
Not applicableUnknownNCT05092568
What this trial is testing

Comparison of General Characteristics of Patients Diagnosed COVID-19 (Coronavirus )Positive Followed In Service

Who this might be right for
Coronavirus Disease 2019VacciniaSymptoms and Signs
Saglik Bilimleri Universitesi 45
Testing effectiveness (Phase 2)Study completedNCT01705223
What this trial is testing

Safety and Immunogenicity Study of AIDS Vaccine (Combined Use of DNA Vaccine and Recombinant Vaccinia Virus Tiantan)

Who this might be right for
AIDS
National Center for AIDS/STD Control and Prevention, China CDC 150
Large-scale testing (Phase 3)Study completedNCT02509494
What this trial is testing

Staged Phase 3 Study to Assess the Safety and Immunogenicity of Ebola Candidate Vaccines Ad26.ZEBOV and MVA-BN-Filo

Who this might be right for
Ebola Virus Disease
Janssen Vaccines & Prevention B.V. 1,023
Early research (Phase 1)Study completedNCT00423566
What this trial is testing

A Phase I Study of the Safety and Immunogenicity of a Recombinant MVA Vaccine Encoding a Secreted Antigen From M. Tuberculosis, Antigen 85A, Delivered Intradermally by a Needle Injection in Healthy Volunteers.

Who this might be right for
Tuberculosis
University of Oxford 14
Not applicableLooking for participantsNCT07185243
What this trial is testing

Evaluate Combination Therapy of Oncolytic Vaccinia Virus (hV01) and PD-1 Inhibitor in Advanced Solid Tumors.

Who this might be right for
Advanced Solid Tumors
Hangzhou Converd Co., Ltd. 24
Testing effectiveness (Phase 2)Ended earlyNCT01329809
What this trial is testing

Neoadjuvant Study of Recombinant Vaccinia Virus to Treat Metastatic Colorectal Carcinoma in Patients Undergoing Complete Resection of Liver Tumors

Who this might be right for
Colorectal Carcinoma
Jennerex Biotherapeutics 2
Not applicableEnrolling By InvitationNCT01374984
What this trial is testing

VA-005 Clinical Outcomes of VIGIV Treatment of Smallpox Vaccination Complications or Vaccinia Infection

Who this might be right for
Complication of Smallpox Vaccination
Emergent BioSolutions 100
Not applicableStudy completedNCT06650722
What this trial is testing

Evaluation of Healthcare Workers Knowledge Regarding Their Vaccination Status at Melun Hospital

Who this might be right for
Vaccinia
Groupe Hospitalier Sud Ile-de-France 100
Testing effectiveness (Phase 2)Ended earlyNCT04725331
What this trial is testing

A Clinical Trial Assessing BT-001 Alone and in Combination With Pembrolizumab in Metastatic or Advanced Solid Tumors

Who this might be right for
Metastatic CancerSoft Tissue SarcomaMerkel Cell Carcinoma+3 more
Transgene 31
Early research (Phase 1)Study completedNCT03615911
What this trial is testing

Safety, Tolerability and Immunogenicity of Vaccine Candidate MVA-MERS-S

Who this might be right for
MERS (Middle East Respiratory Syndrome)
Marylyn Addo 26
Early research (Phase 1)Ended earlyNCT00282581
What this trial is testing

Safety Study of MVA Smallpox Vaccine in HIV-positive Subjects Who Are Vaccinia Naive

Who this might be right for
HIV InfectionsSmallpox
Sanofi Pasteur, a Sanofi Company 2
Next Page